Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

ClinicalTrials.gov ID: NCT04845178

Public ClinicalTrials.gov record NCT04845178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 7:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2 trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per month. The study will enroll 765 patients across approximately 64 sites in the United States, Canada and Australia. Study subjects will be divided evenly across a low dose group, a high dose group and a placebo group. All patients will receive two treatment cycles of ABP-450 or placebo utilizing the Company's novel injection paradigm.

Study identification

NCT ID
NCT04845178
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AEON Biopharma, Inc.
Industry
Enrollment
797 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2021
Primary completion
Jun 18, 2024
Completion
Aug 5, 2024
Last update posted
Sep 3, 2024

2021 – 2024

United States locations

U.S. sites
54
U.S. states
24
U.S. cities
52
Facility City State ZIP Site status
MDFirst Research Chandler Arizona 85226
Elite Clinical Studies, LLC Phoenix Arizona 85018
Arizona Neuroscience Research Phoenix Arizona 85032
Clinical Research Consortium Arizona Tempe Arizona 85281
Axiom Research LLC Colton California 92324
Velocity Research San Diego La Mesa California 91942
Collaborative Neuroscience Research Long Beach California 90806
Los Angeles Headache Center Los Angeles California 90067
Anderson Clinical Research Redlands California 92374
Artemis Institute For Clinical Research LLC - San Diego - ClinEdge - PPDS San Diego California 92103
Delta Waves LLC - Hunt - PPDS Colorado Springs Colorado 80918
Paradigm Clinical Research Centers Wheat Ridge Colorado 80033
New England Institute for Neurology and Headache Stamford Connecticut 06905
Quality Research of South Florida Hialeah Florida 33016
Sandhill Research, LLC Lake Mary Florida 32746
Canvas Clinical Research Lake Worth Florida 33467
BioMed Research Institute, INC Miami Florida 33126
Medical Research Center, LLC Miami Florida 33144
Renstar Medical Research Ocala Florida 34470
Innovation Medical Research Center Palmetto Bay Florida 33157
Clinical Research of Central Florida - ClinEdge - PPDS Winter Haven Florida 33810
NeuroTrials Research Inc. - Clinedge - PPDS Atlanta Georgia 30328
Drug Studies America, Inc Marietta Georgia 30060
Velocity Clinical Research - Boise - ERN - PPDS Meridian Idaho 83642
Cedar Crosse Research Center Chicago Illinois 60607
Kansas Institute of Research, LLC Overland Park Kansas 66211
Crescent City Headache and Neurology Center Chalmette Louisiana 70043
Tandem Clinical Research Marrero Louisiana 70072
Boston Clinical Trials Inc Boston Massachusetts 02131
MedVadis Research Waltham Massachusetts 02451
Quest Research Institute - Hunt - PPDS Farmington Hills Michigan 40825
Henry Ford Allegiance Neurology Jackson Michigan 49201
StudyMetrix Research, LLC City of Saint Peters Missouri 63303
Clinvest Research LLC Springfield Missouri 65810
Barrett Clinic, P.C. - Clinedge - PPDS La Vista Nebraska 68128
Quality Clinical Research Omaha Nebraska 68114
Wake Research - CRCN, LLC Las Vegas Nevada 89118
Hassman Research Institute - ClinEdge - PPDS Berlin New Jersey 08009
Albuquerque Clinical Trials Inc Albuquerque New Mexico 87102
Dent Neurologic Institute Amherst New York 14226
New York Neurology Associates New York New York 10003
Upstate Clinical Research Associates LLC Williamsville New York 14221
Dayton Center for Neurological Disorders Centerville Ohio 45459
META Medical Research Institute, LLC Dayton Ohio 45432
Centricity Research Dublin Multispecialty Dublin Ohio 43016
The Orthopedic Foundation New Albany Ohio 43054
Thomas Jefferson University, Jefferson Headache Center Philadelphia Pennsylvania 19107
Preferred Primary Care Physicians Pittsburgh Pennsylvania 15236
WR-ClinSearch Chattanooga Tennessee 37421
Bryant Research Group Nashville Tennessee 37203
DCT - Baxter LLC dba Discovery Clinical Trials Dallas Texas 75225
Mercury Clinical Research Incorporated Sugar Land Texas 77478
Aspen Clinical Research LLC - Clinedge - PPDS Orem Utah 84058
Northwest Clinical Research Center Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04845178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2024 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04845178 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →